Furthermore, elevated expression of programmed cell death-ligand 1 (PD-L1) is seen in both lung cancer and IPF, where PD-L1, a cell surface protein, interacts with the PD1 receptor on T-cells, leading to immune response suppression and contributing to the pathogenesis of these diseases [32]. The gene discussed is CD274; the disease is lung carcinoma.